Djibouti

in page functions
[French]
Djibouti
Total population (2018) 923,177
Birth cohort (2018) 21,765
Surviving Infants (surviving to 1 year per year, 2018) 20,680
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 54/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 65/1000
World Bank Index, IDA (2015) 2.97
Gross Nation Income (per capita US$, 2005) 1,030
Co-financing group (2018) Preparatory transition
No. of districts/territories (2017) 6

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Djibouti

Type of support

Approvals

2001-2023 (US$)
(26 Sep 2018)

Commitments

2001-2023 (US$)
(26 Sep 2018)

Disbursements

2000-2018 (US$)
(26 Sep 2018)

% Disbursed

(26 Sep 2018)
2002 2003 2004 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $8,012,525 $9,558,025 $7,771,815
Cold Chain Equipment Optimisation Platform (CCEOP) $270,252 $270,252 $188,417 70%
Health system strengthening (HSS 1) $2,756,480 $3,436,480 $2,220,841 81%
Immunisation services support (ISS) $169,300 $169,300 $169,300 100%
Injection Safety Devices (NVS) $15,500 $31,500 $28,873 186%
Injection safety support (INS) $33,900 $33,900 $33,900 100%
IPV (NVS) $89,912 $89,912 $67,018 75%
Penta (NVS) $1,742,788 $1,845,788 $1,776,975 102%
Pneumo (NVS) $2,081,582 $2,636,082 $2,426,752 117%
Rotavirus (NVS) $452,811 $644,811 $459,739 102%
Vaccine Introduction Grant (VIG) $400,000 $400,000 $400,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Djibouti DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 79%
M:F sex ratio at birth (2018) 1.04
Household survey: Last DTP3 survey (2009) 61%
% districts achieving > 80% DTP3 coverage (2017) 17%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 75%

Breakdown of support

Non-vaccine support Vaccine support
39% 61%
$3,012,458 $4,759,357

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Djibouti

19 September 2016

Yemen

Yemen - adaptability in adversity

Dr Osama Mere was born in Damascus and graduated from medical college at Damascus University in 1990. For five years, he served as head of Child Health and the national manager of the Extended Programme for Immunization (EPI) in Syria. In 2015, he became the acting country representative in Yemen for WHO. We talked to him about how Gavi has adapted its health system strengthening to ensure vaccines are still being delivered despite Yemen’s ongoing conflict.

05 October 2012

Tanzania rotavirus rollout Sister Moshi

Useful information

Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping
 

25 May 2012

The Permanent Secretary in the Ministry of Health administers the first Rotateq to a child at Gataraga, Musanze

Rwanda introduces new vaccine against a leading childhood killer

Rotavirus vaccines will protect children from severe and deadly diarrhoea.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here